| Model Number |
TV-IL1414160-J |
| Medical Device Problem Code |
Complete Blockage (1094)
|
| Health Effect - Clinical Code |
Failure of Implant (1924)
|
| Date of Event |
03/18/2021
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
The device remains implanted in the patient; therefore, it will not be returned for evaluation.Patient medical records and imaging studies will be requested for further evaluation by the clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
|
| |
|
Event or Problem Description
|
|
The patient was initially implanted with an alto stent graft main body and two (2) ovation ix limb extensions to treat an abdominal aortic aneurysm.Approximately, five (5) months post initial implant, occlusion with limb compression was identified on the ovation ix left limb likely due to thrombosis.The patient has declined treatment and was reported as doing well.The patient will be monitored.
|
| |
|
Event or Problem Description
|
|
The patient was initially implanted with an alto stent graft main body and two (2) ovation ix limb extensions to treat an abdominal aortic aneurysm.Approximately, five (5) months post initial implant, occlusion with limb compression was identified on the ovation ix left limb likely due to thrombosis.The patient has declined treatment and was reported as doing well.The patient will be monitored.Additional information: subsequent to the initial report, clinical assessment identified evidence of a type ii (non-device related) endoleak from inferior mesenteric artery.
|
| |
|
Additional Manufacturer Narrative
|
|
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident-related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the left limb stent complete occlusion was confirmed.This is consistent with the reported adverse event/incident.The clinical evaluation also shows reasonable evidence to suggest the procedure-related harms identified were type 2 endoleak from inferior mesenteric artery.The most likely causation for the complete left limb occlusion is the tortuous left iliac artery and narrow bifurcation diameter.The average measurement at the bifurcation on pre-ct was 15.2mm, which is likely to cause a narrowing of the limb stent.Ifu states: -the aortic bifurcation should be able to accommodate the two 9 mm iliac limbs of the alto¿ system.The final patient status was reported as being monitored.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Corrections: b5: describe event or problem.G1,2: contact office- name has been updated.G4: date of received by manufacturer.H6: result code: remove code 3233.H6: conclusion code: remove code 11.
|
| |
|
Search Alerts/Recalls
|